Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/28854| Title: | Durable clinical efficacy of alemtuzumab in patients with active RRMS in the absence of continuous treatment: 7-year follow-up of CARE-MS I patients (TOPAZ study) | Authors: | McCombe, Pamela Boyko, Alexey N. DeSeze, Jerome Hartung, Hans-Peter Havrdova, Eva Inshasi, Jihad Said Montalban, Xavier Pozzilli, Carlo Selmaj, Krzysztof W. Vermersch, Patrick Melanson, Maria Daizadeh, Nadia Rodriguez, Claudio E. VAN WIJMEERSCH, Bart |
Issue Date: | 2018 | Publisher: | BMJ PUBLISHING GROUP | Source: | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89(6), p. E18-E19 (Art N° 044) | Notes: | [McCombe, Pamela] Univ Queensland, Brisbane, Qld, Australia. [Boyko, Alexey N.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, Alexey N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [DeSeze, Jerome] Univ Strasbourg, Strasbourg, France. [Hartung, Hans-Peter] Heinrich Heine Univ, Dusseldorf, Germany. [Havrdova, Eva] Charles Univ Prague, Fac Med 1, Prague, Czech Republic. [Inshasi, Jihad Said] Rashid Hosp, Dubai, U Arab Emirates. [Inshasi, Jihad Said] Dubai Med Coll, Dubai, U Arab Emirates. [Montalban, Xavier] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Montalban, Xavier] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain. [Pozzilli, Carlo] Univ Rome, Rome, Italy. [Selmaj, Krzysztof W.] Med Univ Lodz, Lodz, Poland. [Vermersch, Patrick] Univ Lille, Lille, France. [Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, Bart] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. | Document URI: | http://hdl.handle.net/1942/28854 | ISSN: | 0022-3050 | e-ISSN: | 1468-330X | DOI: | 10.1136/jnnp-2018-ANZAN.43 | ISI #: | 000438056200044 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.